Skip to content
Recall Observatory FDA recall evidence

Drug product

Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-410-02

D-0661-2026

June 29, 2026

Class II

Product summary

Firm
Cipla USA, Inc.
Event
Event 99350
Status
Ongoing
Classification
Class II
Quantity
31,824 bottles
Official record key
drug-enforcement:D-0661-2026

Official wording

Reason: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Code information: Lot #: 5PB0465, 5PB0466, 5PB0557, Exp 4/30/2027; 5PB0629, 5PB0630, 5PB0633, 5PB0637, 5PB0638, Exp 6/30/2027

Distribution pattern: USA Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations